Table 1.

Patients’ characteristics, biochemical test, ultrasound results, and treatment course used for treatment

Patients	Gender	Age	S. Creatinine mg/dl	INR	S Albumin g/dl	ALT IU/L	AST IU/L	Genotype	U/S of liver	City	Treatment Course
Patient 1	F	58	6	1.2	4.2	130	80	1a	Normal	Zakho	Sofo400/Ledipasvir90
Patient 2	M	66	8	1.3	4.26	14	29	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 3	F	45	9.9	1.01	4.3	240	103	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 4	F	60	5	1.37	3.25	83	103	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 5	M	27	9	1.37	3.04	45	33	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 6	F	50	8	1.39	3.54	97	128	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 7	M	61	6	1.16	3.8	202	249	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 8	M	60	5	0.79	3.9	70	77	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 9	M	38	8	1.33	3.55	184	169	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 10	F	63	10.4	1.03	3.1	441	156	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 11	F	47	6	1.06	4.4	33	41	1a	Normal	Duhok	Sofo200/Daclas 60
Patient 12	F	68	11	1.1	4.36	29	14	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 13	M	75	6	1.17	3.7	103	65	1a	Normal	Zakho	Sofo400/ Ledipasvir90
Patient 14	F	60	7	1.17	3.7	34	52	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 15	F	37	8	1.1	4.8	35	17	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 16	M	38	8	1	3.7	480	400	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 17	M	70	2.8	1.1	3.18	28	19	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 18	M	68	5	1	3.88	76	64	1a	Normal	Zakho	Sofo200/Daclas 60
Patient 19	M	50	11	1	4.13	6	12	1a	Normal	Zakho	Sofo200/Daclas 60